Ahmed El-Ghannam1, Hany Amin, Tamer Nasr, Ashraf Shama. 1. University of Kentucky, Center for Biomedical Engineering, Wenner Gren Research Laboratory, Graduate School, School of Dentistry, Lexington, Kentucky 40506-0070, USA. arelgh2@uky.edu
Abstract
PURPOSE: Bioactive glass bonds to bone through a calcium phosphate layer that mimics the structure of the mineral phase of bone. Formation of this layer is inhibited in the presence of serum protein. The authors hypothesize that creation of a calcium phosphate layer on the surface of bioactive glass before implantation will enhance bone regeneration and graft material resorption in bone defects. MATERIALS AND METHODS: Bioactive glass particles covered with a layer of amorphous calcium phosphate (BG-ACP), bioactive glass particles covered with a layer of hydroxycarbonate apatite (BG-HCA), and unmodified bioactive glass particles (as a control) were prepared and implanted in cortical bone defects in dogs or in human maxillary cavities. Ungrafted sites were also used as a control. RESULTS: Histomorphometric analyses showed significantly more bone tissue regeneration and graft material resorption in the defects filled with BG-HCA than in those filled with BG-ACP or unmodified bioactive glass (P < .0001). Moreover, measurements of radiographic density of the grafted areas suggested a higher rate of bone regeneration in defects filled with the modified bioactive glass than in those filled with unmodified bioactive glass or in the ungrafted control. Bone formation was significantly greater in defects filled with unmodified bioactive glass particles than in ungrafted defects. DISCUSSION: The enhancement of bone regeneration could be explained by the ability of the apatite layer to facilitate bone adsorption and enhance calcium release, which stimulates osteoblast differentiation and bone formation. CONCLUSION: Results of both the clinical and animal studies suggest that the use of surface-modified bioactive glass covered with a hydroxycarbonate apatite layer has the potential to accelerate bone formation and graft material resorption better than unmodified bioactive glass.
PURPOSE: Bioactive glass bonds to bone through a calcium phosphate layer that mimics the structure of the mineral phase of bone. Formation of this layer is inhibited in the presence of serum protein. The authors hypothesize that creation of a calcium phosphate layer on the surface of bioactive glass before implantation will enhance bone regeneration and graft material resorption in bone defects. MATERIALS AND METHODS: Bioactive glass particles covered with a layer of amorphous calcium phosphate (BG-ACP), bioactive glass particles covered with a layer of hydroxycarbonate apatite (BG-HCA), and unmodified bioactive glass particles (as a control) were prepared and implanted in cortical bone defects in dogs or in human maxillary cavities. Ungrafted sites were also used as a control. RESULTS: Histomorphometric analyses showed significantly more bone tissue regeneration and graft material resorption in the defects filled with BG-HCA than in those filled with BG-ACP or unmodified bioactive glass (P < .0001). Moreover, measurements of radiographic density of the grafted areas suggested a higher rate of bone regeneration in defects filled with the modified bioactive glass than in those filled with unmodified bioactive glass or in the ungrafted control. Bone formation was significantly greater in defects filled with unmodified bioactive glass particles than in ungrafted defects. DISCUSSION: The enhancement of bone regeneration could be explained by the ability of the apatite layer to facilitate bone adsorption and enhance calcium release, which stimulates osteoblast differentiation and bone formation. CONCLUSION: Results of both the clinical and animal studies suggest that the use of surface-modified bioactive glass covered with a hydroxycarbonate apatite layer has the potential to accelerate bone formation and graft material resorption better than unmodified bioactive glass.
Authors: Alayna E Loiselle; Lai Wei; Muhammad Faryad; Emmanuel M Paul; Gregory S Lewis; Jun Gao; Akhlesh Lakhtakia; Henry J Donahue Journal: Tissue Eng Part A Date: 2013-04-25 Impact factor: 3.845
Authors: Vivekanand S Kattimani; P Srinivas Chakravarthi; Narasimha Reddy Kanumuru; Vummidisetti V Subbarao; A Sidharthan; T S Sampath Kumar; L Krishna Prasad Journal: J Int Oral Health Date: 2014-06-26
Authors: Ariadne Cristiane Cabral da Cruz; Márcia Thaís Pochapski; Ricardo Tramonti; José Caetano Zurita da Silva; Augusto Celso Antunes; Gibson Luiz Pilatti; Fábio André Santos Journal: J Mater Sci Mater Med Date: 2008-03-06 Impact factor: 3.896
Authors: Montse Charles-Harris; Martin A Koch; Melba Navarro; Damien Lacroix; Elisabeth Engel; Josep A Planell Journal: J Mater Sci Mater Med Date: 2008-02-12 Impact factor: 3.896